ID
15678
Description
Nerventra Study (Eudra CT 2007-003226-19) Study MS-LAQ-301: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the safety, tolerability and efficacy of daily oral administration of laquinimod 0.6 mg in subjects with relapsing remitting multiple sclerosis (RRMS)
Keywords
Versions (1)
- 6/8/16 6/8/16 -
Uploaded on
June 8, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Nerventra Study Termination/Early termination
Nerventra Study Termination/Early termination
- StudyEvent: ODM
Description
Termination/Early termination
Description
Last dose
Data type
date
Alias
- UMLS CUI [1,1]
- C1762893
- UMLS CUI [1,2]
- C3854006
Description
Clinical trial drug code broken
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3854006
- UMLS CUI [1,2]
- C0349677
- UMLS CUI [1,3]
- C0175566
Description
Study drug code broken
Data type
text
Alias
- UMLS CUI [1,1]
- C3854006
- UMLS CUI [1,2]
- C0349677
- UMLS CUI [1,3]
- C0175566
Description
Completion of trial
Data type
boolean
Alias
- UMLS CUI [1]
- C2732579
Description
Withdrawal
Data type
integer
Alias
- UMLS CUI [1,1]
- C2349954
- UMLS CUI [1,2]
- C1549995
Description
Comments
Data type
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C2349954
Similar models
Nerventra Study Termination/Early termination
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C3854006 (UMLS CUI [1,2])
C0349677 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,3])
C0349677 (UMLS CUI [1,2])
C0175566 (UMLS CUI [1,3])
C1549995 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,2])